SMAD3 and hepatocellular carcinoma: Corresponding IHC staining showed that NSUN5‐overexpressing tumors exhibited elevated SMAD3 protein expression, leading to enhanced SMAD3 signaling pathway activity (p‐SMAD3), thereby promoting EMT in HCC.